The collected sample may have a low concentration of the target molecules, making them difficult to be detected.
NEXT
DIAGNOSTICS PERFORM THE
CRITICAL FUNCTION OF
IDENTIFYING THREATS TO
OUR WELLBEING
The potential benefits of accurate diagnostics are immense , but target molecules that indicate the presence of disease often exist in quantities too low to be detected in collected samples.
PHASE Scientific has developed an
innovative solution to the problem of
low-concentration target molecule
detection.
PHASIFY™ improves the performance
of point-of-care and lab-based
diagnostics.
By improving sample quality,
our technology increases the sensitivity, performance
and affordability of point-of-care and
lab-based tests.
A TRANSFORMATION IN
DISEASE DETECTION AND TREATMENT
Enhanced diagnostic tools produce more accurate and
accessible health information.
These tools support prevention and earlier treatment,
improving outcomes and lowering healthcare costs.

FOR INDIVIDUALS
Increased decision-making and
ownership over their health.

FOR HEALTHCARE PROVIDERS
Greater ability to diagnose and
treat diseases.

FOR POLICYMAKERS
New tools that facilitate timely
detection and treatment decisions
to control diseases.